Tag Archives: Mersana Therapeutics

February, 2016

  • 8 February

    Takeda Expands its ADC Collaboration with Mersana

    CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Mersana Therapeutics and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that they have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate, XMT-1522, outside the United States and Canada. The deal also expands an existing collaboration between the companies to provide …